<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641405</url>
  </required_header>
  <id_info>
    <org_study_id>CE/PROG.478</org_study_id>
    <nct_id>NCT02641405</nct_id>
  </id_info>
  <brief_title>Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study</brief_title>
  <acronym>PAGE</acronym>
  <official_title>Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>I.R.C.C.S. Fondazione Santa Lucia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istituto Auxologico Italiano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS National Neurological Institute &quot;C. Mondino&quot; Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale S. Raffaele Arcangelo, Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Genova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>I.R.C.C.S. Fondazione Santa Lucia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It's already known the efficacy of Gait Analysis (GA) on evaluating gait modification on&#xD;
      Parkinson's Disease (PD) Patients (1). On the other hand Proprioceptive Focal Stimulation&#xD;
      seems be useful in symptoms amelioration in several neurological disease. Few studies have&#xD;
      been performed in Parkinson's disease. A total of 126 patients suffering from PD will be&#xD;
      recruited in 6 italian neurological centers. The study will be a cross-over multicenter study&#xD;
      with the randomization of the sequence. The patients will be randomly assigned to 2 groups&#xD;
      receiving for 8 weeks either the Equistasi medical device, or an equivalent placebo. Gait&#xD;
      analysis will be recorded in each patient at the beginning and at the end of the treatment&#xD;
      assigned. After 4 weeks of wash-out, the treatment will be crossed and a new gait analysis&#xD;
      recording will be performed. Finally a last recording will be taken at the end of the last 8&#xD;
      weeks. Secondary outcome will be the MDS-UPDRS (Movement Disorder Society - Unified Parkinson&#xD;
      Disease Rating Scale), PDQ-39 (Parkinson Disease 39 Questionnaire ), ABC (Activity Specific&#xD;
      Balance Confidence Scale).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Spatio-Temporal gait variables at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the Movement Disorder Society - Unified Parkinson Disease Rating Scale (MDS-UPDRS) - at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Parkinson Disease 39 Questionnaire (PDQ-39) at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Activity Specific Balance Confidence Scale (ABC scale) at 20 weeks</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Gait, Shuffling</condition>
  <condition>Effects of Vibration</condition>
  <arm_group>
    <arm_group_label>Equistasi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inactive Equistasi will be given to every patient in the form of three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Equistasi</intervention_name>
    <description>Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
    <arm_group_label>Equistasi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inactive Equistasi</intervention_name>
    <description>Inactive Equistasi will be given to every patient in the form of three patches to be placed at C7 and at the gastrocnemial junction of both legs.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with rigid-acinetic bilateral PD form&#xD;
&#xD;
          -  At least 4 years of disease history&#xD;
&#xD;
          -  H&amp;Y between 2-3&#xD;
&#xD;
          -  Stable drug therapy response without any change performed in the 3 months before the&#xD;
             study.&#xD;
&#xD;
          -  Presence of freezing (FOG) and of postural instability not responding to parkinsonian&#xD;
             therapy.&#xD;
&#xD;
          -  MMSE&gt;24/30 (Mini-Mental State Examination)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic illness&#xD;
&#xD;
          -  Presence of cardiac pacemaker&#xD;
&#xD;
          -  Presence of deep brain stimulation&#xD;
&#xD;
          -  Presence of severe dysautonomia with marked hypotension&#xD;
&#xD;
          -  Obsessive-Compulsive disorder (OCD)&#xD;
&#xD;
          -  Major depression&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  History or active neoplasia&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS Santa Lucia</name>
      <address>
        <city>Rome</city>
        <state>Lazio</state>
        <zip>00179</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS National Neurological Institute &quot;C. Mondino&quot; Foundation</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Auxologico Italiano</name>
      <address>
        <city>Oggebbio</city>
        <state>Verbano-Cusio-Ossola</state>
        <zip>28824</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele</name>
      <address>
        <city>Cassino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Genova</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Raffaele Arcangelo, Fatebenefratelli</name>
      <address>
        <city>Venezia</city>
        <zip>30121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 3, 2015</study_first_submitted>
  <study_first_submitted_qc>December 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>January 9, 2021</last_update_submitted>
  <last_update_submitted_qc>January 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>I.R.C.C.S. Fondazione Santa Lucia</investigator_affiliation>
    <investigator_full_name>Antonella Peppe</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Gait analysis</keyword>
  <keyword>Proprioceptive focal stimulation</keyword>
  <keyword>Parkinson</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Gait Disorders, Neurologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

